501121-34-2
501121-34-2 结构式
基本信息
中文别名
阿伐他汀钠盐阿托伐他汀EP杂质E
阿托伐他汀USP相关物质E
英文别名
S,S-Atorvastatin3S,5S-Atorvastatin Sodium
Atorvastatin EP Impurity E
S,S-Atorvastatin Sodium Salt
(3S,5S)-Atorvastatin Sodium Salt
Atorvastatin USP Related CoMpound E
(bS,dS)-2-(4-Fluorophenyl)-b,d-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid
1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, (βS,δS)-
(S,dS)-2-(4-Fluorophenyl)-,d-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Sodium
(βS,δS)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-Methylethyl)-3-phenyl-4-[(phenylaMino)carbonyl]-1H-pyrrole-1-heptanoic Acid SodiuM
常见问题列表
生物活性
(3S,5S)-Atorvastatin 是 Atorvastatin 的无活性对映异构体。(3S,5S)-Atorvastatin 可以激活孕烷 X 受体 (PXR)。Atorvastatin 是一种具有口服活性的 HMG-CoA 还原酶抑制剂，具有有效降低血脂的能力。靶点
Pregnane X receptor (PXR)
体外研究
Atorvastatin and its inactive enantiomer (3S,5S)-Atorvastatin increases CYP2B and CYP3A mRNA content with equal ability.
(3S,5S)-Atorvastatin in 100 μM concentrations induces luciferase activity with an EC
50
of 12.4 μM.
Addition of (3S,5S)-Atorvastatin to the 2-formylphenylboronic
acid (FPBA)/l-tryptophanol mixture induces an intensity enhancement of l-tryptophanol florescence.